3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Endocrine
1
Conditions
Breast Neoplasms
2
Pituitary Neoplasms
1
Abdominal Cancer
1
Interventions
pasireotide
4
Cabergoline
3
Surgical Procedures, Operative
2
Propofol
2
Octreotide
2
Human Growth Hormone
2
pegvisomant
1
entinostat
1
corticorelin ovine
1
Yoga
1
Thyrotropin-Releasing Hormone
1
Surveys and Questionnaires
1
Supine Position
1
Sevoflurane
1
Resistance Training
1
Radiotherapy
1
Radiosurgery
1
Photochemotherapy
1
Nivolumab
1
Neurosurgical Procedures
1
Lapatinib
1
Ipilimumab
1
Ibuprofen
1
Hydrocortisone
1
Growth Hormone
1
Dosage Forms
1
Dihematoporphyrin Ether
1
Dexamethasone
1
Desflurane
1
Continuous Glucose Monitoring
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Pituitary Neoplasms
×
Supine Position
×
Clear all
NCT04584866
2025-04-29
PosESS
University Hospital, Basel, Switzerland
Phase NA
Completed
54 enrolled